References
- Muttagi SS , ChaturvediP, GaikwadRet al. Head and neck squamous cell carcinoma in chronic areca nut chewing Indian women: case series and review of literature. Indian J. Med. Paediatr. Oncol.33(1), 32–35 (2012).
- Shih Y-H , WangT-H, ShiehT-Met al. Oral submucous fibrosis: a review on etiopathogenesis, diagnosis, and therapy. Int. J. Mol. Sci.20(12), 2940 (2019).
- Chang Y-C , LinC-W, YuC-Cet al. Resveratrol suppresses myofibroblast activity of human buccal mucosal fibroblasts through the epigenetic inhibition of ZEB1 expression. Oncotarget7(11), 12137–12149 (2016).
- Lu M-Y , YuC-C, ChenP-Yet al. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts. J. Formos. Med. Assoc.117(9), 791–797 (2018).
- Humphries B , YangC. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy. Oncotarget6(9), 6472–6498 (2015).
- Lin C-Y , LiaoY-W, HsiehP-Let al. LncRNA GAS5-AS1 inhibits myofibroblasts activities in oral submucous fibrosis. J. Formos. Med. Assoc.117(8), 727–733 (2018).
- Kalluri R , NeilsonEG. Epithelial– mesenchymal transition and its implications for fibrosis. J. Clin. Invest.112(12), 1776–1784 (2003).
- Xiong M , JiangL, ZhouYet al. The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am. J. Physiol. Renal Physiol.302(3), F369–F379 (2012).
- Hessin AF , HegazyRR, HassanAAet al. Resveratrol prevents liver fibrosis via two possible pathways: modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses. Indian J. Pharmacol.49(4), 282–289 (2017).